Disulfiram is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Disulfiram.
Product ID | 47781-607_7934ffcc-0025-30a6-7d7e-4a9356a643c0 |
NDC | 47781-607 |
Product Type | Human Prescription Drug |
Proprietary Name | Disulfiram |
Generic Name | Disulfiram |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2013-08-09 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA091681 |
Labeler Name | Alvogen Inc. |
Substance Name | DISULFIRAM |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Acetyl Aldehyde Dehydrogenase Inhibitors [MoA],Aldehyde Dehydrogenase Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2013-08-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA091681 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-08-09 |
Marketing End Date | 2017-12-31 |
Marketing Category | ANDA |
Application Number | ANDA091681 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-08-09 |
Ingredient | Strength |
---|---|
DISULFIRAM | 250 mg/1 |
SPL SET ID: | b90f8ff4-4fb3-46ab-8149-cb55f24a4044 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0054-0356 | Disulfiram | Disulfiram |
0054-0357 | Disulfiram | Disulfiram |
0093-5035 | Disulfiram | Disulfiram |
0093-5036 | Disulfiram | Disulfiram |
0378-4140 | Disulfiram | disulfiram |
0378-4141 | Disulfiram | disulfiram |
42794-028 | Disulfiram | Disulfiram |
47781-607 | Disulfiram | Disulfiram |
60429-196 | Disulfiram | Disulfiram |
62135-431 | Disulfiram | Disulfiram |
62135-432 | Disulfiram | Disulfiram |
64980-171 | Disulfiram | Disulfiram |
64980-172 | Disulfiram | Disulfiram |
68151-2694 | Disulfiram | Disulfiram |
51285-523 | Antabuse | Disulfiram |
51285-524 | Antabuse | Disulfiram |